What is GEHC stock price today?

GEHC (Ge Healthcare Technologies Inc) stock is trading at $84.27 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is GEHC stock going up or down today?

GEHC stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy GEHC stock now?

The decision to buy GEHC depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is GEHC a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for GEHC based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is GEHC stock overvalued or undervalued?

GEHC currently trades at a P/E ratio of 18.52 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if GEHC is fairly priced.

What is GEHC's P/E ratio?

GEHC has a price-to-earnings (P/E) ratio of 18.52, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is GEHC's market cap?

GEHC (Ge Healthcare Technologies Inc) has a market capitalization of $38.41 billion, making it a mid-cap stock.

What is GEHC's price to book ratio?

GEHC trades at a price-to-book (P/B) ratio of 3.69, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does GEHC pay dividends?

Yes, GEHC pays dividends with a current yield of 0.00%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is GEHC's dividend yield?

GEHC's dividend yield is 0.00%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is GEHC stock a good long-term investment?

GEHC's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is GEHC's revenue growth rate?

GEHC has shown revenue growth of 0.1% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, GEHC is profitable with a profit margin of 0.1%. This indicates the company generates 0.1 cents of profit for every dollar of revenue.

What are the risks of investing in GEHC?

Key risks for GEHC include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does GEHC compare to its competitors?

Compare GEHC to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize GEHC's performance and positioning.

What is GEHC's stock price target for 2026?

Our AI model provides price targets for GEHC based on fundamental analysis: Bull case $109.55 (+30%), Base case $96.91 (+15%), Bear case $75.84 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about GEHC?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for GEHC. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is GEHC's next earnings report?

GEHC reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

GEHC - Ge Healthcare Technologies Inc

NYSE * Health Care * Health Care Technology

$84.27

+$0.35 (+0.42%)

About Ge Healthcare Technologies Inc

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

GEHC Key Statistics

Market Cap

$38.41B

P/E Ratio

18.52

P/B Ratio

3.69

EPS

$4.55

Dividend Yield

0.00%

Revenue Growth

+0.1%

Profit Margin

0.1%

Employees

54,000

How GEHC Compares to Peers

GEHC has the lowest P/E ratio in Health Care Technology, suggesting it may be the most undervalued

GEHC is the smallest among peers, which may offer higher growth potential

P/E Rank

of 2

Margin Rank

of 2

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
GEHC(This stock)	$38.41B	18.5	0%	0.1%	-
AMZNAmazon Com	$2.23T	29.0	0%	0.1%	vs AMZN

Ge Healthcare Technologies Inc Company Information

Headquarters: Illinois; U.S.A
Website: www.gehealthcare.com
Sector: Health Care
Industry: Health Care Technology

GEHC - Ge Healthcare Technologies Inc

About Ge Healthcare Technologies Inc

GEHC Key Statistics

How GEHC Compares to Peers

Ge Healthcare Technologies Inc Company Information

GEHC Lician Score

GEHC Financial Snowflake

Upcoming Events for GEHC